These two runs perfectly demonstrate how switching to a **Categorical Visit** model provides a clearer "clinical story" than a simple monthly slope. You now have specific snapshots of recovery.

Here is the breakdown of your results and how to interpret them for your Tier 2 analysis:

---

### 1. Direct Interpretation of the "Visit" Coefficients

In these runs, **T0 (Baseline)** is the hidden reference point inside the Intercept. The coefficients for T1, T2, and T3 represent the **mean improvement** compared to day zero.

* **Non-Linear Progress:** In Run 1, the jump from T0 to T1 (+1.91) is smaller than the jump from T2 to T3 (3.42 to 6.46). This suggests an accelerating recovery or a larger impact at the one-year mark.
* **Statistical Significance:** In Run 2, the improvement at 3 months () is barely significant, whereas the improvement at 12 months is massive ().
* *Clinical takeaway:* If this were real data, you would report that "significant QoL gains are achieved as early as 3 months, but the most substantial clinical benefit is realized at 12 months."



### 2. The Stability of CEAP and BMI

Even with the change in the "Time" variable, your secondary variables remain robust predictors:

* **CEAP "Stepladder":** Notice how the negative coefficients grow steadily larger as you move from C2 to C6. The difference between C2 (-3.8) and C6 (-21.4) is consistent across both runs.
* **The BMI Tax:** In Run 2, the BMI effect is much stronger (-1.03 vs -0.38). This suggests that in that specific mock cohort, weight had a nearly 3x larger impact on QoL than in Run 1.

---

### 3. Comparing the Model Fits (Run 1 vs Run 2)

| Metric | Run 1 Interpretation | Run 2 Interpretation |
| --- | --- | --- |
| **Recovery Path** | Steady/Late gain. | Slower start, strong finish. |
| **C2 Significance** | C2 is significantly worse than C1 (). | C2 is not significantly different from C1 (). |
| **Group Var** | 22.9 | 22.7 |
| **Scale (Error)** | 5.54 | 4.41 |

**Note on Group Var:** The fact that your **Group Var (22.7)** is nearly **5 times larger** than your **Scale (4.4)** proves that the "Subject Effect" is dominant. Some patients are just "high-scorers" and some are "low-scorers" regardless of their CEAP; the LMM is correctly capturing this by giving each patient their own starting point.

---

### 4. Updated LaTeX Model for Categorical Visits

Since you changed from `Month` (continuous) to `Visit` (categorical), your formal equation for the paper should now look like this:

**Where:**

* : Represents the specific QoL shift at the -th follow-up visit compared to baseline.
* All other variables remain as previously defined.

---

### Final Next Step Recommendation

Your mock is now statistically sophisticated. Would you like me to help you create a **Publication-Ready Table** (using Python or Markdown) that combines these two runs, showing the Coefficients, Standard Errors, and P-values in a format suitable for a journal's "Results" section?